XML 43 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Note 9 - Stockholders' Equity and Equity Compensation
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

9.

STOCKHOLDERS’ EQUITY AND EQUITY COMPENSATION

 

Share Repurchase Plan

 

In December 2019, the Company’s board of directors authorized the open market repurchase of up to an additional two million shares of the Company’s common stock upon completion of the two million share repurchase program approved by the board of directors in December 2018. As of March 31, 2020, 327,161 shares remained to be repurchased under the 2018 program and an additional two million shares under the 2019 program. Any shares repurchased are pursuant to one or more trading plans established in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. In March 2020, the Company’s board of directors suspended the applicable 10b5-1 trading plans for the current open market repurchase program to increase liquidity and improve financial flexibility in light of COVID-19. The prior authorizations of the board of directors remain in effect as the program did not establish a time period in which the repurchases had to be made. As of March 31, 2020, the authorization was limited to $40.0 million in 2020 by the Company’s amended Credit Facility while the Company’s consolidated financial leverage ratio remained greater than 2.50 to 1.00. See Note 14 for additional information on further amendments to the amended Credit Facility, effective April 29, 2020.

 

At March 31, 2020, the Company was also authorized to repurchase up to $10.0 million of the Company’s common stock in each calendar year in connection with the Company’s equity compensation programs for employees. The participants in the Company’s equity plans may surrender shares of common stock in satisfaction of tax obligations arising from the vesting of restricted stock, restricted stock unit awards and performance unit awards under such plans and in connection with the exercise of stock option awards. The deemed price paid is the closing price of the Company’s common stock on the Nasdaq Global Select Market on the date that the restricted stock, restricted stock unit or performance unit vests or the shares of the Company’s common stock are surrendered in exchange for stock option exercises. With regard to stock option awards, the option holder may elect a “net, net” exercise in connection with the exercise of employee stock options such that the option holder receives a number of shares equal to the built-in gain in the option shares divided by the market price of the Company’s common stock on the date of exercise, less a number of shares equal to the taxes due upon the exercise of the option divided by the market price of the Company’s common stock on the date of exercise. The shares of common stock surrendered for taxes due on the exercise of the option are deemed repurchased by the Company. See Note 14 for additional information on further amendments to the amended Credit Facility, effective April 29, 2020.

 

During the first quarter of 2020, the Company acquired 180,491 shares of the Company’s common stock for $3.2 million ($17.80 average price per share) through the open market repurchase program discussed above, and 80,129 shares of the Company’s common stock for $1.8 million ($22.87 average price per share) in connection with the satisfaction of tax obligations in connection with the vesting of restricted stock units and performance units. Once repurchased, the Company immediately retired all such shares.

 

During the first quarter of 2019, the Company acquired 622,043 shares of the Company’s common stock for $11.1 million ($17.82 average price per share) through open market repurchases, 152,946 shares of the Company’s common stock for $3.1 million ($20.48 average price per share) in connection with the satisfaction of tax obligations in connection with the vesting of restricted stock, restricted stock units and performance units, and 48,409 shares of the Company’s common stock for $1.0 million ($20.52 average price per share) in connection with “net, net” exercises of employee stock options. Once repurchased, the Company immediately retired all such shares.

 

Equity-Based Compensation Plans

 

In April 2016, the Company’s stockholders approved the 2016 Employee Equity Incentive Plan, which was amended in 2017 by the First Amendment to the 2016 Employee Equity Incentive Plan (as amended, the “2016 Employee Plan”). In April 2018, the Company’s stockholders approved the Second Amendment to the 2016 Employee Equity Incentive Plan, which increased by 1,700,000 the number of shares of the Company’s common stock reserved and available for issuance in connection with awards issued under the 2016 Employee Plan. The 2016 Employee Plan, which replaced the 2013 Employee Equity Incentive Plan, provides for equity-based compensation awards, including restricted shares of common stock, performance awards, stock options, stock units and stock appreciation rights. The 2016 Employee Plan is administered by the Compensation Committee of the board of directors, which determines eligibility, timing, pricing, amount and other terms or conditions of awards. As of March 31, 2020, 1,598,572 shares of the Company’s common stock were available for issuance under the 2016 Employee Plan.

 

In April 2016, the Company’s stockholders approved the 2016 Non-Employee Director Equity Incentive Plan (the “2016 Director Plan”), which replaced the 2011 Non-Employee Director Equity Incentive Plan. In April 2019, the Company’s stockholders approved an amendment and restatement of the 2016 Director Plan, which among other things, increased by 300,000 the number of shares of the Company’s common stock reserved and available for issuance in connection with awards issued under the 2016 Director Plan. The 2016 Director Plan provides for equity-based compensation awards, including non-qualified stock options and stock units. The board of directors administers the 2016 Director Plan and has the authority to establish, amend and rescind any rules and regulations related to the 2016 Director Plan. As of March 31, 2020, 319,168 shares of the Company’s common stock were available for issuance under the 2016 Director Plan.

 

Stock Awards

 

Stock awards, which include shares of restricted stock, restricted stock units and performance stock units, are awarded from time to time to executive officers and certain key employees of the Company. Stock award compensation is recorded based on the award date fair value and charged to expense ratably through the requisite service period. The forfeiture of unvested restricted stock, restricted stock units and performance stock units causes the reversal of all previous expense to be recorded as a reduction of current period expense.

 

A summary of the stock award activity is as follows:

 

   

Stock Awards

   

Weighted Average Award Date Fair Value

 

Outstanding at December 31, 2019

    1,034,964     $ 23.20  
Period Activity:                

Restricted stock units awarded

    229,971       22.96  

Performance stock units awarded

    131,755       22.96  

Restricted stock units distributed

    (152,596 )     23.15  

Performance stock units distributed

    (71,541 )     28.18  

Restricted stock units forfeited

    (15,717 )     20.84  

Performance stock units forfeited

    (76,282 )     27.46  

Outstanding at March 31, 2020

    1,080,554     $ 22.53  

 

Expense associated with stock awards was $1.8 million and $2.0 million for the quarters ended March 31, 2020 and 2019, respectively. Unrecognized pre-tax expense of $16.1 million related to stock awards is expected to be recognized over the weighted average remaining service period of 2.27 years for awards outstanding at March 31, 2020.

 

Deferred Stock Unit Awards

 

Deferred stock units are generally awarded to directors of the Company and represent the Company’s obligation to transfer one share of the Company’s common stock to the grantee at a future date. Historically, awards were fully vested, and fully expensed, on the date of grant. Beginning in April 2019, as a result of the amendment and restatement of the 2016 Director Plan discussed above, the expense related to the issuance of deferred stock units is based on the award date fair value and charged to expense ratably through the requisite service period, which is generally one year. The forfeiture of unvested deferred stock units causes the reversal of all previous expense to be recorded as a reduction of current period expense.

 

A summary of deferred stock unit activity is as follows:

 

   

Deferred Stock Units

   

Weighted Average Award Date Fair Value

 

Outstanding at December 31, 2019

    253,340     $ 20.71  
Period Activity:                

Awarded

    2,238       22.11  

Distributed

           

Outstanding at March 31, 2020

    255,578     $ 20.72  

 

Expense associated with deferred stock unit awards was $0.3 million and $0.1 million for the quarters ended March 31, 2020 and 2019, respectively. Unrecognized pre-tax expense is less than $0.1 million related to deferred stock unit awards is expected to be recognized over the weighted average service period of 0.1 years for awards outstanding at March 31, 2020.

 

Stock Options

 

Stock options on the Company’s common stock were previously awarded from time to time to executive officers and certain key employees of the Company. Stock options granted generally had a term of seven to ten years and an exercise price equal to the market value of the underlying common stock on the date of grant. There were 52,783 stock options exercised during the first quarter of 2019 with a weighted average exercise price of $18.11 per share. There were nostock options outstanding at March 31, 2020 and December 31, 2019.